In the present review, there were four AD/MCI studies that stratified patients according to their APOE-ε4 carrier status [33, 36, 41, 53], with the remaining AD studies not indicating the APOE-ε4 status of the sample. This evidence concerns the gene APOE and Alzheimer disease.